CROI 2024 Report Back: Treatment Updates

Поделиться
HTML-код
  • Опубликовано: 14 апр 2024
  • Dr. Jehan Budak summarizes key study results from the CROI 2024 conference that focus on antiretroviral treatment, especially long-acting injectable cabotegravir/rilpivirine and lenacapavir.

Комментарии •